Clinical Trial Update: Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

View source ↗

Summary

The document reports clinical outcomes from a trial evaluating tislelizumab in combination with chemotherapy as induction therapy for stage III non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: West China Hospital | Conditions: NSCLC Stage IIIB, NSCLC Stage IIIC | Status: NOT_YET_RECRUITING